CA2181351A1 - Process and Intermediates for Preparing Naphthyridonecarboxylic Acid Salts - Google Patents

Process and Intermediates for Preparing Naphthyridonecarboxylic Acid Salts

Info

Publication number
CA2181351A1
CA2181351A1 CA2181351A CA2181351A CA2181351A1 CA 2181351 A1 CA2181351 A1 CA 2181351A1 CA 2181351 A CA2181351 A CA 2181351A CA 2181351 A CA2181351 A CA 2181351A CA 2181351 A1 CA2181351 A1 CA 2181351A1
Authority
CA
Canada
Prior art keywords
intermediates
alpha
acid salts
preparing
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2181351A
Other languages
French (fr)
Other versions
CA2181351C (en
Inventor
Tamim F. Braish
Darrell E. Fox
Timothy Norris
Peter R. Rose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Tamim F. Braish
Darrell E. Fox
Timothy Norris
Peter R. Rose
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tamim F. Braish, Darrell E. Fox, Timothy Norris, Peter R. Rose, Pfizer Inc. filed Critical Tamim F. Braish
Publication of CA2181351A1 publication Critical patent/CA2181351A1/en
Application granted granted Critical
Publication of CA2181351C publication Critical patent/CA2181351C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention relates to novel processes for preparing compounds of formula (I), wherein R1H is as defined below, which is a salt of the naphthyridone antibiotic 7-(1.alpha.,5.alpha.,6.alpha.)-(6-amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carbocylic acid and a pharmaceutically acceptable acid. The salt and antibiotics have antibacterial activity. This invention also relates to novel intermediates, and processes for their preparation, of formulae (IV), (IIIB) or (IIIA). The compounds of formulae (IIIA), (IIIB) and (IV) are useful as intermediates in the syntheses of the azabicyclo naphthyridone carboxylic acid alkanesulfonic acid salts of formula (I).
CA002181351A 1994-01-18 1994-12-12 Process and intermediates for preparing naphthyridonecarboxylic acid salts Expired - Fee Related CA2181351C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18194294A 1994-01-18 1994-01-18
US08/181,942 1994-01-18
PCT/IB1994/000410 WO1995019361A1 (en) 1994-01-18 1994-12-12 Process and intermediates for preparing naphthyridonecarboxylic acid salts

Publications (2)

Publication Number Publication Date
CA2181351A1 true CA2181351A1 (en) 1995-07-20
CA2181351C CA2181351C (en) 1999-09-28

Family

ID=22666458

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002181351A Expired - Fee Related CA2181351C (en) 1994-01-18 1994-12-12 Process and intermediates for preparing naphthyridonecarboxylic acid salts

Country Status (19)

Country Link
EP (1) EP0740667A1 (en)
JP (1) JP2891543B2 (en)
KR (1) KR100221386B1 (en)
CN (1) CN1141634A (en)
AU (1) AU694149B2 (en)
BR (1) BR9408490A (en)
CA (1) CA2181351C (en)
CZ (1) CZ286896B6 (en)
FI (1) FI962880A0 (en)
HU (1) HUT74883A (en)
IL (1) IL112323A (en)
MY (1) MY130510A (en)
NO (1) NO305838B1 (en)
NZ (1) NZ276478A (en)
PL (1) PL179996B1 (en)
RU (1) RU2147303C1 (en)
TW (1) TW414791B (en)
WO (1) WO1995019361A1 (en)
ZA (1) ZA95340B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223404C (en) * 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
ES2095809B1 (en) * 1995-07-27 1997-12-16 Sint Quimica Sa PROCEDURE FOR THE PREPARATION OF NAFTIRIDIN CARBOXYLIC ACIDS AND THEIR SALTS.
GB9524466D0 (en) * 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (en) * 1996-07-09 1998-04-07 Pfizer Inc Production of intermediate useful for synthesizing quinoline-based antibiotic
GB9614422D0 (en) * 1996-07-09 1996-09-04 Pfizer Ltd Novel process
HN1998000106A (en) 1997-08-01 1999-01-08 Pfizer Prod Inc PARENTERAL COMPOSITIONS OF ALATROFLAXACINO
HN1999000141A (en) * 1998-09-03 2000-06-19 Pfizer Prod Inc PROCEDURE FOR PREPARING SALTS OF TROVAFLOXACIN FOR ADDITION OF ACIDS.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
PL179996B1 (en) 2000-11-30
CZ211196A3 (en) 1997-01-15
EP0740667A1 (en) 1996-11-06
NZ276478A (en) 1998-05-27
HUT74883A (en) 1997-02-28
PL317043A1 (en) 1997-03-03
CN1141634A (en) 1997-01-29
MY130510A (en) 2007-06-29
JP2891543B2 (en) 1999-05-17
AU1075495A (en) 1995-08-01
KR100221386B1 (en) 1999-09-15
AU694149B2 (en) 1998-07-16
IL112323A (en) 2001-03-19
CZ286896B6 (en) 2000-07-12
NO962990D0 (en) 1996-07-17
ZA95340B (en) 1996-07-17
NO305838B1 (en) 1999-08-02
WO1995019361A1 (en) 1995-07-20
NO962990L (en) 1996-07-17
FI962880A (en) 1996-07-17
IL112323A0 (en) 1995-03-30
FI962880A0 (en) 1996-07-17
RU2147303C1 (en) 2000-04-10
CA2181351C (en) 1999-09-28
HU9601957D0 (en) 1996-09-30
TW414791B (en) 2000-12-11
BR9408490A (en) 1997-08-26
JPH09501182A (en) 1997-02-04

Similar Documents

Publication Publication Date Title
AU608881B2 (en) Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent
AP9600817A0 (en) Novel cryatal form of anhydrous 7-( [1A,5A,6A]-6-amino3-3-azabicyclo [3.1.0.] hex-3-yl) -6-fluro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt.
AU666772B2 (en) Quinolone carboxylic acids
CA2223404A1 (en) Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
IE883900L (en) Antibacterial agents
CA2209487A1 (en) Imidazo[4,5-c]quinoline amines
CA2175372A1 (en) Novel 9-hydroxy-pyrido[1,2-a]pyrimidin-4-one ether derivatives
PT85411A (en) 7-]]3-(aminomethyl)-3-alkyl"-1-pyrrolidinyl"-quinoline-carboxylic acids
RU96111026A (en) 7 - ([1A, 5A, 6A] -6-AMINO-3-AZABICYCLO [3.1.0.] HEX-3-IL) -6-fluoro-1- (2,4-difluorophenyl) -1,4-dihydro -4-OXO-1,8- NAPHTHIRIDINE-3-CARBONIC ACID, METHANESULPHIC ACID SALT, METHOD FOR PRODUCING IT, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT
EP0335297A3 (en) Cephalosporin derivatives
CA2181351A1 (en) Process and Intermediates for Preparing Naphthyridonecarboxylic Acid Salts
CA2131160A1 (en) Preparation of Intermediates in the Synthesis of Quinoline Antibiotics
EP0393424A3 (en) Process for the preparation of 2,7-Diazabicyclo(3.3.O)octanes
CA2013087A1 (en) Carbonate derivatives of eseroline, a process for their preparation and their use as medicaments
DE4234330A1 (en) Quinolonecarboxylic acids
IE61722B1 (en) Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents
CA2033937A1 (en) Hemihydrate
CA2344439A1 (en) Process for the production of a naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate)
WO2001017961A3 (en) Intermediates for the production of naphthyridine-3-carboxylic acid derivatives
GR3015422T3 (en) Thiadiazolylacetamide cephem derivatives.
CA2224616A1 (en) Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
CA2220080A1 (en) Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
CZ230195A3 (en) Process for preparing condensed carbapenem derivative and intermediate for preparing thereof
IT1275422B (en) Cyclohexane cephalosporins and process for their preparation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed